1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA KLHL20 CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA SLX4IP CTRPv2 pan-cancer AAC 0.11 0.0007
mRNA GIMAP6 CTRPv2 pan-cancer AAC 0.11 0.0007
mRNA SLC25A40 CTRPv2 pan-cancer AAC 0.11 0.0007
mRNA STX11 CTRPv2 pan-cancer AAC -0.11 0.0007
mRNA EFNB3 CTRPv2 pan-cancer AAC 0.11 0.0007
mRNA AC138645.1 CTRPv2 pan-cancer AAC 0.11 0.0007
mRNA USP42 CTRPv2 pan-cancer AAC 0.11 0.0007
mRNA DRAP1 CTRPv2 pan-cancer AAC -0.11 0.0007
mRNA NMNAT3 CTRPv2 pan-cancer AAC 0.11 0.0007
Download CSV